These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 8345981
1. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981 [Abstract] [Full Text] [Related]
2. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines. Decker MD, Edwards KM, Bradley R, Palmer P. J Pediatr; 1992 Feb; 120(2 Pt 1):184-9. PubMed ID: 1735812 [Abstract] [Full Text] [Related]
3. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh JE, Anderson EL. JAMA; 1994 Oct 12; 272(14):1116-21. PubMed ID: 7933324 [Abstract] [Full Text] [Related]
4. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, Medley F, Murphy TV. J Pediatr; 1992 Aug 12; 121(2):187-94. PubMed ID: 1640282 [Abstract] [Full Text] [Related]
5. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants. Anderson EL, Decker MD, Englund JA, Edwards KM, Anderson P, McInnes P, Belshe RB. JAMA; 1995 Mar 15; 273(11):849-53. PubMed ID: 7869554 [Abstract] [Full Text] [Related]
6. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH. Vaccine; 1993 Mar 15; 11 Suppl 1():S46-51. PubMed ID: 8447176 [Abstract] [Full Text] [Related]
7. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Heath PT. Pediatr Infect Dis J; 1998 Sep 15; 17(9 Suppl):S117-22. PubMed ID: 9781743 [Abstract] [Full Text] [Related]
8. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants. Holmes SJ, Fritzell B, Guito KP, Esbenshade JF, Blatter MM, Reisinger KS, Keyserling HL, Rothstein EP, Bernstein HH, Feldman S. Am J Dis Child; 1993 Aug 15; 147(8):832-6. PubMed ID: 8352217 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Santosham M, Hill J, Wolff M, Reid R, Lukacs L, Ahonkhai V. Pediatr Infect Dis J; 1991 Feb 15; 10(2):113-7. PubMed ID: 2062601 [Abstract] [Full Text] [Related]
10. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants. Capeding MR, Nohynek H, Pascual LG, Kayhty H, Sombrero LT, Eskola J, Ruutu P. Am J Trop Med Hyg; 1996 Nov 15; 55(5):516-20. PubMed ID: 8940983 [Abstract] [Full Text] [Related]
11. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B, Wald E, Guerra N, Byers C. Pediatrics; 1990 Apr 15; 85(4 Pt 2):682-9. PubMed ID: 2107519 [Abstract] [Full Text] [Related]
12. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. Santosham M, Rivin B, Wolff M, Reid R, Newcomer W, Letson GW, Almeido-Hill J, Thompson C, Siber GR. J Infect Dis; 1992 Jun 15; 165 Suppl 1():S144-51. PubMed ID: 1588150 [Abstract] [Full Text] [Related]
13. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group. Ward J, Brenneman G, Letson GW, Heyward WL. N Engl J Med; 1990 Nov 15; 323(20):1393-401. PubMed ID: 2233906 [Abstract] [Full Text] [Related]
14. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. Decker MD, Edwards KM, Bradley R, Palmer P. J Pediatr; 1993 Mar 15; 122(3):410-3. PubMed ID: 8441096 [Abstract] [Full Text] [Related]
16. Finnish efficacy trials with Haemophilus influenzae type b vaccines. Eskola J, Peltola H, Käyhty H, Takala AK, Mäkelä PH. J Infect Dis; 1992 Jun 15; 165 Suppl 1():S137-8. PubMed ID: 1588148 [Abstract] [Full Text] [Related]
17. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. Vella PP, Ellis RW. Pediatr Res; 1991 Jan 15; 29(1):10-3. PubMed ID: 2000253 [Abstract] [Full Text] [Related]
18. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. CMAJ; 1993 Jan 15; 148(2):199-214. PubMed ID: 8452591 [No Abstract] [Full Text] [Related]
19. Antibodies against Haemophilus influenzae type b and tetanus in infants after subcutaneous vaccination with PRP-T/diphtheria, or PRP-OMP/diphtheria-tetanus vaccines. Carlsson RM, Claesson BA, Iwarson S, Lagergård T, Käyhty H. Pediatr Infect Dis J; 1994 Jan 15; 13(1):27-33. PubMed ID: 8170729 [Abstract] [Full Text] [Related]
20. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. Schlesinger Y, Granoff DM. JAMA; 1992 Mar 18; 267(11):1489-94. PubMed ID: 1538539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]